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Abstract
Background: Nonencapsulated Streptococcus pneumoniae bacteria are successful colonizers of the human
nasopharynx and often possess genes aliB-like ORF 1 and 2 in place of capsule genes. AliB-like ORF 2 binds peptide
FPPQSV, found in Prevotella species, resulting in enhanced colonization. How this response is mediated is so far
unknown.
Results: Here we show that the peptide increases expression of genes involved in release of host carbohydrates,
carbohydrate uptake and carbohydrate metabolism. In particular, the peptide increased expression of 1,5-anhydro-
D-fructose reductase, a metabolic enzyme of an alternative starch and glycogen degrading pathway found in many
organisms, in both transcriptomic and proteomic data. The peptide enhanced pneumococcal growth giving a
competitive advantage to a strain with aliB-like ORF 2, over its mutant lacking the gene.
Possession of aliB-like ORF 2 did not affect release of inflammatory cytokine CXCL8 from epithelial cells in culture
and the nonencapsulated wild type strain was not able to establish disease or inflammation in an infant rat model
of meningitis.
Conclusions: We propose that AliB-like ORF 2 confers an advantage in colonization by enhancing carbohydrate
metabolism resulting in a boost in growth. This may explain the widespread presence of aliB-like ORF 2 in the
nonencapsulated pneumococcal population in the human nasopharynx.
Keywords: Streptococcus pneumoniae, Peptide, Nonencapsulated, aliB-like ORF 2, Transcriptome, Proteome
Background
Streptococcus pneumoniae causes several human diseases
including bacterial meningitis, pneumonia, sepsis and
otitis media but more often inhabits the human
nasopharynx without causing disease. It shares this niche
with many other organisms and we have previously
proposed that pneumococcus senses its bacterial neigh-
bours by recognizing peptide fragments derived from
them [1]. Of pneumococcal strains that lack genes to
synthesize a polysaccharide capsule, the majority possess
in their stead two genes named aliB-like ORF 1 and
ORF 2 which we predict encode substrate-binding
proteins of an ATP-binding cassette (ABC) transporter
[2, 3]. Nonencapsulated pneumococci which lack capsule
genes but have aliB-like ORF 1 and ORF 2 are commonly
of multilocus sequence types 344 or 448 and close
relatives, which make up a separate phylogenetic group
that clusters away from the majority of encapsulated
pneumococci [3–5]. As well as being efficient colonizers
of the nasophynyx, these nonencapsulated strains, particu-
larly ST448, are associated with conjunctivitis and have
been proposed to be adapted to these niches by distinct
virulence factors and metabolic features which differ from
those of encapsulated pneumococci [6]. The aliB-like
ORF 1 and ORF 2 genes are also found in strains of the
commensal streptococci S. mitis, S. oralis and S. pseudop-
neumoniae [7–9]. By expressing AliB-like ORF 1 and ORF
2 proteins, we have previously shown that they bind to
peptides SETTFGRDFN (found in the 50S ribsosomal
subunit protein L4 of Enterobacteriaceae) and FPPQSV
(found in proteins of Prevotella species) respectively.
Binding of the ORF 1 ligand was associated with upregula-
tion of competence for genetic transformation whereas
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binding of ORF 2 ligand aided the pneumococcal
colonization of the nasopharynx [1]. Understanding the
communication that occurs between bacterial species in
their natural environment may provide novel targets with
which to interfere.
Here, we investigated how binding of AliB-like ORF 2
to its ligand causes phenotypic changes to the pneumo-
coccus. We determined the changes caused by the
peptide ligand to the pneumococcal transcriptome and
proteome and the effect on growth in vitro. We also
determined the effect of pneumococci with and without
AliB-like ORF 2 on host cells in vitro and in an infant
rat model of meningitis.
Methods
Ethics statement
All animal studies were approved by the Animal Care
and Experimentation Committee of the Canton of Bern,
Switzerland (licence BE76/14) and followed the Swiss
national guidelines for the performance of animal
experiments.
Bacterial culture and strains
Bacteria were stored and cultured as described previously
[1] i.e., storage using Protect bacterial preservers (Tech-
nical Service Consultants, Heywood, U.K.) at − 80 °C. To
grow the pneumococci they were first streaked onto
Columbia sheep blood agar (CSBA) plates and then
incubated at 37 °C, 5% CO2 overnight. Cultures of 3 to 10
colonies were next prepared in 5 ml brain heart infusion
(BHI) broth (Becton Dickinson and Company, le Pont
de Claix, France) containing 5% fetal calf serum (FCS)
(Biochrom KG, Berlin, Germany) for overnight culture.
The Swiss nonencapsulated nasopharyngeal pneumo-
coccal isolate 110.58 of multilocus sequence type
(MLST) ST344 [2], and the construction of its mutants
in which one or both of its aliB-like ORFs have been
inactivated to give mutants ΔORF 2 and ΔORF 1 + 2 has
been previously described [1, 2].
Preparation of bacteria and measurement of growth
Following overnight growth on CSBA plates at 37 °C, 5%
CO2, the bacteria were subcultured in BHI + FCS
medium, grown to OD600nm 0.5 and subsequently centri-
fuged at 3000 g for 5 min before resuspension in chem-
ically defined CDM medium which contains 5.5 mM
glucose [10]. Growth was monitored as described previ-
ously [11] in sterile flat-bottomed 96-well microtitre
plates (Nunclon Surface, Nunc, Denmark) based on the
method of Brewster [12] as follows: 200 μl bacteria
culture was incubated per well at 37 °C and OD450nm
was measured at 30 min intervals by a VERSAmax micro-
plate reader (Molecular Devices) over 20 h with 5 s of
automatic shaking preceding each reading. Condensation
was prevented by pre-treating the plate lids with 3 ml 0.
05% Triton X-100 in 20% ethanol [11].
Growth competition assay
Wild type strain 110.58 and mutant ΔORF 2 were
streaked onto CSBA plates and incubated at 37 °C in a
5% CO2-enriched atmosphere overnight then subcul-
tured in BHI + FCS medium to OD600nm 0.5, centrifuged
at 3000 g for 5 min and resuspended in chemically
defined CDM medium. 250 μl of each bacterial culture
was transferred to 4.5 ml CDM pre-warmed to 37 °C
and AliB-like ORF 2 ligand FPPQSV (synthesized by
PolyPeptide Group, Strasbourg, France) was added to a
final concentration of 0.07 mg/ml (104 μM) and the cul-
ture incubated to an OD600nm 0.3. Serial dilutions in
PBS were plated onto CSBA plates with and without
3 μg/ml chloramphenicol to differentiate between wild
type (chloramphenicol susceptible) and mutant ΔORF 2
(resistant) strains. After overnight incubation, the num-
ber of colonies was counted and the colony forming
units (CFU) for each strain calculated. (CFU for mutant
was calculated from the number of colonies on the
chloramphenicol plates, CFU for wild type was calcu-
lated from the number of colonies on the CSBA plates
minus the number on the chloramphenicol plates).
Gene expression analysis by RNA-Seq and real-time RT-PCR
RNA-Seq was used to identify differentially expressed
genes between wild type and ΔORF 2 mutant as well as
wild type compared to wild type exposed to the peptide
ligand and the ΔORF 2 mutant compared to ORF 2
treated with the ligand.
110.58 and ΔORF 2 were plated out on CSBA plates
and incubated at 37 °C, 5% CO2 overnight, colonies
picked and cultured overnight in 5 ml BHI + FCS as
described above until OD600nm = 0.4 then centrifuged at
2000 g for 5 min and the pellet resuspended in CDM.
The centrifugation was repeated and the pellet resus-
pended in 5 ml CDM. This 5 ml bacterial suspension
was added to 10 ml CDM. For each strain, at exactly
OD600nm = 0.2 the culture was split into two tubes, each
containing 5 ml. To one tube for each strain the peptide
FPPQSV was added to give a final concentration of 0.
07 mg/ml, mixed and all tubes incubated at 37 °C for
exactly 15 min. Transcription was stopped by adding
RNAprotect (Qiagen) and RNA extracted as described
previously [13]. RNA was isolated from three separate
experiments performed on different days for RNA-Seq
and from a further three separate experiments per-
formed on different days for real-time RT-PCR.
For RNA-Seq, ribosomal RNA was depleted using
Ribominus (Invitrogen) and then the RNA purified using
RNA Clean & Concentration™-5 kit (Zymo Research)
according to the manufacturers’ instructions, eluting in
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6 μl. Libraries were prepared using TruSeq® Stranded
mRNA (Illumina). 13 μl Fragment, Prime, Finish Mix
was added to 5 μl of the mRNA. Fragmentation was
performed for 40 s at 94 °C. Raw reads were obtained
from an Illumina 3000 Hi-seq paired end sequencing
platform. Reads were mapped to Streptococcus pneumoniae
strain NT_110_58 assembly gca 000817005 ASM81700v1).
Preprocessing and adapter triming was done using the Tri-
mommatic tool (0.35) [14]. Alignments were performed
with Bowtie (bowtie2–2.2.8) [15]. Cufflinks (cufflinks-2.2.1)
and Cuffdiff were used to count reads and calculate differ-
ential gene expression [16]. Quality control and coverage
were examined using FastQC (0.11.5) and Qualimap 2.2.1
[17]. The sequencing and coverage was on average 3557
times the genome size (ranging between 543 and 5220).
The mean length of sequenced fragments was 141 bp.
Mapping to the reference genome was above 99.09% for all
samples.
Expression of genes of interest identified by RNA-Seq
was quantified by real-time RT-PCR as described
previously [13] and normalized against 16S using the
following primers and probes: 16S forward primer 5’-
GACGATACATAGCCGACCTGAGA-3′; reverse primer
5’-GTAGGAGTCTGGGCCGTGTCT-3′; probe 6-
carboxyfluorescein (6-FAM)-CCAGTGTGGCCGATC-
minor groove binder (MGB); afr forward primer 5′- TC
TTCATCACCGAAATGTTCACCTT-3′; reverse primer
5′- ATGCCTGAAACTGTAACCATGACA-3′; probe,
(6FAM)- ATGGGCCACATTTCCA-(MGB); adhE for-
ward primer 5’-GAAGGAAGTTTCATCCATTGCAT
GT-3′; reverse primer 5’-ACGTTAGTGCCATTAA
CCTCTTGAA-3′; probe (6-FAM)-CCGTCTTCCGAC
TTTT-(MGB); nanA_3 forward primer 5’-CACCACTT-
CACCAGCAGATGTATAA-3′; reverse primer 5’-GAG
ACTAAAGTTCCAATAACGACTGGTT-3′; probe (6-
FAM)-CACGCACCATTTTCTT–(MGB); nanB forward
primer 5’-GTTAACCCAACTTTAGCAATGGCAAT-3′;
reverse primer 5’-GGAGCAATCATGTCGAGAC-
TACT-3′; probe (6-FAM)-TTCCCACCAATTTTG-
(MGB); yesO_2 forward primer 5’-ACTTGGTTAGGA
AGAGCTGTACTGA-3′; reverse primer 5’-GAATGA
CTTCTATACTAAATGGACTACAGGTT-3′; probe
(6-FAM)-ATCTGGCACATTTCC-(MGB); ycjO for-
ward primer 5’-GAAGTGGCGTACTCTGTGAAGA-
3′; reverse primer 5’-TGGACCGTTTTCTCATTAG
TTGGT-3′; probe (6-FAM)-AAGCCAATACAAACC
C-(MGB).
Proteomic analysis
Sample processing, LC-MS/MS and data interpretation
was essentially done as described previously [18] with
the following minor changes. LC-MS/MS analysis was
carried out on an Ultimate3000 nanoLC coupled to an
Orbitrap Fusion Lumos instrument (ThermoFisher
Scientific) acquiring full MS scans in the m/z range
400–1400 in the orbitrap at resolution 120′000 with
AGC set to 4e5 and maximal ion injection time of
50 ms. Peptide precursors with charge 2–8 were frag-
mented once in the iontrap then excluded for 30s. The
iontrap setting were data-dependent MS2 cycle time of
3 s, isolation width of 1.6 m/z, fragmentation HCD
mode with 30% normalized collision energy, AGC of 1e4
with maximal ion injection time of 35 ms. The LC-MS/
MS data was processed with MaxQuant (version 1.5.4.1)
using default settings for peak detection, strict trypsin
cleavage rule allowing for up to three missed cleavages,
variable oxidation on methionine and acetylation of
protein N-termini with strict carbamidomethylation of
cysteines. Match between runs was activated with a re-
tention time window of 0.7 min. The fragment spectra
were interpreted with the Streptococcus pneumoniae en-
semble database (version gca_000817005_ASM81700v1).
For data analysis, peptide feature intensities reported in
the evidence file were median normalized and missing
values were imputed from the low end of the LOG2
transformed intensity distribution of each LC-MS/MS
run using Perseus (version 1.5.5.3) as suggested by Lazar
et al. [19]. The three most intense peptide feature inten-
sities were summed for the individual protein group
intensity.
Detroit cell culture and CXCL8 (IL-8) cytokine assay
CXCL8 levels were measured as described previously
[20]. The human pharyngeal epithelial cell line Detroit
562 (ATCC CCL-138) was cultured in complete medium
at 37 °C at 5% CO2. This was composed of Minimum
Essential Media (MEM) with 10% heat-inactivated fetal
calf serum (FCS), 2 mM of L-glutamine, 1% sodium
bicarbonate, 1× MEM non-essential amino acid solution,
1 mM sodium pyruvate (all from Gibco, Life Technolo-
gies, Switzerland), 100 μg/ml streptomycin and 100 U/
ml penicillin. 0.05% Trypsin-EDTA (Gibco, Switzerland)
was used to harvest the cells when they reached 70–90%
confluence. The production of CXCL8 in response to
exposure to S. pneumoniae was determined as described
previously [20] as follows.
3 × 105 Detroit cells in 1 ml MEM without antibiotics,
was added per well of a 24-well plate (TPP tissue culture
plates, Sigma-Aldrich,) which was then incubated over-
night at 37 °C, 5% CO2. Integrity of the monolayer on
the following day was checked by microscopy. The
medium was replaced in each well by 0.5 ml MEM
without FCS or antibiotics. A suspension of bacteria
(strain 110.58 or one of its mutants ΔORF 1 + 2 or
ΔORF 2) of approximately 6 × 106 CFU/ml was made to
give an estimated MOI of 10. Serial dilutions of the
suspension were made and plated out to enable accurate
quantification of CFU/ml, and therefore the MOI. 0.5 ml
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MEM containing the bacteria (3 × 106 CFU) was added
per well. For those wells which received ORF2 ligand
peptide FPPQSV, it was added to give a concentration of
0.07 mg/ml. The plate was centrifuged at 120 g for
3 min at 25 °C and then incubated at 37 °C, 5% CO2.
After an incubation of a total of 24 h at 37 °C, 5% CO2,
the supernatant was collected in 1.5 ml tubes, spun at
20000 g for 3 min at room temperature and the
supernatant collected and stored at − 80 °C for later
analysis. CXCL8 concentrations were measured by
ELISA (R&D systems ELISA kits, Abingdon, United
Kingdom). Experiments were performed in triplicate on
three different days.
Infant rat model of pneumococcal meningitis
A well-established infant rat model of bacterial meningi-
tis [21] adapted to strains not previously passaged in
animals [22] was used as follows. As in our previous
publication [22] a litter of 12 nursing Wistar rats with
their dam was obtained from Charles River (Sulzfeld,
Germany) and given 5 days to acclimatize. At 11 days of
age rats weighing 24.1 ± 2 g were infected intracisternally
with 10 μl 0.85% NaCl containing either 1.25 × 107
colony forming units (CFU)/ml live S. pneumoniae
strain 110.58 or 5 × 106 colony forming units (CFU)/ml
live S. pneumoniae mutant ΔORF 1 + 2. Samples of
cerebrospinal fluid (CSF) were taken at 21 h post
infection (hpi) for quantitative analysis of bacterial
cultures to determine whether there was any bacterial
meningitis. At 21 and 29 hpi the antibiotic ceftriaxone
(Rocephine®, Roche Pharma, Basel, Switzerland; 2 ×
100 mg/kg/d i.p.) was administered. Disease severity was
assessed and CSF sampled as described previously for
determination of cytokine concentrations at 21 and 45
hpi [22]. Animals were sacrificed with an overdose of
pentobarbital (150 mg/kg) at 45 hpi and perfused with
4% paraformaldehyde (PFA) in PBS and then the brains
were removed and fixed in PFA for histological analysis.
The concentration of the cytokines IL-6, IL-1β, TNFα,
IL-10, IFN-γ in the CSF samples was determined using
the microsphere-based multiplex assays (MILLIPLEX®
MAP Kit, Rat Cytokine/Chemokine Magnetic Bead
Panel, Millipore Corporation, Billerica, MA, USA) as de-
scribed previously [23]. Cortical damage and apoptosis
in the hippocampus was assessed as previously described
in animals sacrificed at 45 hpi [21, 23].
Statistical analysis
Statistical analysis of RNA-Seq data was done as previ-
ously described [16]. FDR was taken into account with
Benjamini-Hochberg correction for multiple testing.
Differentially expressed genes were considered signifi-
cant when the p-value of three independent biological
experiments was below 0.5.
For proteomics data analysis t-tests were performed
within Perseus, including a permutation-based false
discovery rate estimation (cutoff at 1% and using SO
function set at 0.5) to correct for multiple testing.
For other experiments student t-tests were performed
to obtain p-values using the software GraphPad Prism
(Version 7, GraphPad Software, Inc.).
Results
AliB-like ORF 2 peptide ligand FPPQSV affects gene
expression
Transcriptome analysis by RNA-Seq was performed for
wild type nonencapsulated pneumococcal strain 110.58,
which possesses aliB-like ORF 1 and ORF 2 in place of
capsule genes, and its mutant lacking aliB-like ORF 2
expression (ΔORF 2) in the presence and absence of
AliB-like ORF 2 peptide ligand FPPQSV. There was a
modest difference in gene expression between the wild
type strain 110.58 and its mutant ΔORF 2 without treat-
ment but exposure to the ORF 2 ligand FPPQSV caused
significant changes in gene expression in strain 110.58
and in mutant ΔORF 2 (Additional file 1: Figure S1 and
Additional files 2: Table S1, Additional file 3: Table S2,
Additional file 4: Table S3, Additional file 5: Table S4).
The top twenty most upregulated genes in the wild type
following exposure to the ORF 2 ligand peptide are
shown in Table 1. This table was produced following
exclusion of those genes for which the wild type treated
with the peptide gave expression values of less than 20
as even such small values could give statistically signifi-
cant results if the control group had an even smaller
value. Genes for which the change in expression was not
significant were also excluded. Of these 20 most upregu-
lated genes, at least 12 are associated with carbohydrate
metabolism or uptake (indicated in Table 1 in bold).
Kegg pathways with genes that were significantly
overrepresented were “ribosomal proteins”, “alanine,
aspartate and glutamate” and “purine metabolism”.
Branched chain amino acid transporters (liv operon)
were also differentially regulated (Additional file 1:
Figure S2).
To verify the RNA-Seq results, we performed real-
time RT-PCR on several genes as follows. The first was
afr which encodes 1,5-anhydro-D-fructose reductase.
We also determined expression of adhE which encodes
a bifunctional acetaldehyde-alcohol dehydrogenase, pri-
marily a fermentative enzyme. AdhE has been proposed
to act as a pneumococcal virulence factor by increasing
expression of pneumolysin and therefore haemolytic
activity [24]. We also tested by real-time RT-PCR the
expression of genes nanA_3 and nanB which encode
sialidases as well as yesO_2, encoding a substrate binding
protein, and ycjO, encoding a permease, of an ABC
transporter for carbohydrate (Fig. 1). nanA_3, nanB,
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yesO_2 and ycjO are located in close proximity to each
other in the genome. According to RNA-Seq results in
Table 1 afr had an increase in expression of 20.2-fold
and adhE of 4.1-fold in the wild type strain when it was
exposed to the peptide. Real-time RT-PCR indicated a
significant 6-fold increase in the expression of afr and
14-fold expression in adhE when exposed to the peptide
(Fig. 1a and b), in line with the RNA-Seq result. Expres-
sion of both genes was also increased in the ΔORF 2
mutant by exposure to the peptide but to a lesser extent
(Fig. 1a and b). The two sialidases (nanA_3 and nanB)
also showed upregulation in response to the ORF 2 pep-
tide in the RT-PCR experiments (Fig. 1c and d) which was
significant in the wild type strain but not the ΔORF 2 mu-
tant. For the carbohydrate ABC transporter genes, both
the substrate binding protein (yesO_2) and permease
(ycjO) were upregulated in both the wild type and the mu-
tant in response to the peptide (Fig. 1e and f). This upreg-
ulation was statistically significant for the mutant only for
yesO_2 and for both the wild type and mutant for ycjO in
contrast to the RNA-Seq results where upregulation was
significant for both yesO_2 and ycjO for the wild type but
not the mutant (Additional file 2: Table S1).
Proteomic data indicate peptide activates metabolism
To determine whether changes seen in gene transcription
are translated into changes at the protein level, proteomic
analysis was performed by LC-MS/MS on wild type strain
110.58 and mutant ΔORF 2 in the presence and absence
of AliB-like ORF 2 peptide ligand FPPQSV. Table 2 shows
all proteins significantly upregulated in 110.58 following
exposure to peptide FPPQSV (see Additional file 6: Table
S5, Additional file 7: Table S6, Additional file 8: Table S7,
Additional file 9: Table S8 for all data). The proteomic and
RNA-Seq datasets were comparable (Additional file 1:
Figure S3) with the top of the list of proteins being Afr
(1,5- anhydro-D-fructose reductase), supporting the RNA
expression data that the peptide may boost carbohydrate
metabolism. In addition, the uracil transporter PyrP was
also found to be upregulated by 3.8 fold in both the RNA-
Seq data (Table 1) and the proteomics data (Table 2).
NanA_3 and NanB, which were upregulated by ORF 2
peptide in the RNA-Seq and real-time RT-PCR data were
not found in the proteomics data.
Since RNA-Seq and proteomic data indicated a boost
in metabolism, we next looked at the effect of ORF 2
peptide on pneumococcal growth.
Table 1 Summary of top 20 genes with expression upregulated in wild type strain 110.58 by exposure to ORF 2 ligand peptide
FPPQSV
Gene number Gene name Function Ratioa q
SpnNT_02141 tRNA-Phe infiniteb 0.03
SpnNT_02309 tRNA-Asn infiniteb 0.03
SpnNT_01742 afr 1,5-anhydro-D-fructose reductase 20.2 0.001
SpnNT_01743 nanB Sialidase 11.9 0.001
SpnNT_01746 yesO_2 Putative ABC transporter for carbohydrate 10.1 0.001
SpnNT_01745 ycjO Putative ABC transporter for carbohydrate 7.5 0.001
SpnNT_01744 ycjP Putative ABC transporter for carbohydrate 7.5 0.001
SpnNT_00088 sorB_1 Sorbose-specific phosphotransferase enzyme IIB component 6.6 0.04
SpnNT_01738 yesO_1 Putative ABC transporter for carbohydrate 6.3 0.001
SpnNT_01747 tabA Toxin-antitoxin biofilm protein TabA 6.2 0.001
SpnNT_01751 nanA_3 Sialidase 5.3 0.001
SpnNT_01537 CsbD-like protein, general stress response protein 4.6 0.001
SpnNT_01944 tRNA-Leu 4.5 0.005
SpnNT_00467 grpE HSP-70 cofactor, heat shock protein 4.4 0.001
SpnNT_01021 pyrP Uracil transporter 4.2 0.001
SpnNT_00091 manX_1 EIIAB-Man, carbohydrate transport 4.1 0.001
SpnNT_00092 agaS Putative tagatose-6-phosphate ketose/aldose isomerase 4.1 0.001
SpnNT_00089 agaC_1 PTS system N-acetylgalactosamine-specific EIIC component 1 4.1 0.001
SpnNT_02080 adhE Aldehyde-alcohol dehydrogenase 4.1 0.001
SpnNT_01032 pyrR Pyrimidine operon attenuation protein/uracil phosphoribosyltransferase 3.8 0.001
Genes names in bold indicate an association with carbohydrate metabolism or uptake. For the complete dataset for the wild type and ΔORF 2 mutant see
Additional files 2: Table S1, Additional file 3: Table S2, Additional file 4: Table S3, Additional file 5: Table S4
aRatio represents the fold increase in the expression of genes in the presence of peptide FPPQSV compared to in its absence
bExpression in the absence of peptide was 0 so fold increase in the presence of peptide could not be calculated
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ORF 2 peptide boosts growth
In CDM, wild type strain 110.58 and mutant ΔORF 2
had a similar pattern of growth. Addition of ORF 2
peptide ligand FPPQSV reduced the lag phase of
growth and increased the maximum OD for both, but
to a greater degree for 110.58 (Fig. 2). For clarity, no
error bars are shown in Fig. 2. Growth curves were
performed with 4 different doses of ORF 2 peptide,
plus no peptide controls, in three independent experi-
ments on three different days. The mean values for
all doses, with error bars showing standard error, are
shown in Additional file 1: Figure S4A. To confirm that
the effect is specific to ORF 2 peptide, growth curves with
and without a control peptide of sequence LRRASLG are
shown in Additional file 1: Figure S4B and indicate
no difference in growth between wildtype and mutant
ΔORF 2.
To determine whether AliB-like ORF 2 gives a
competitive advantage to bacteria which possess it when
ORF 2 peptide is present, we next cultured the wildtype
strain 110.58 and its ΔORF 2 mutant together. Figure 3
shows that when equal numbers of the two strains were
mixed together the wild type 110.58, which has the ORF
2 binding protein, has a competitive advantage and that
this advantage is significantly greater in the presence of
the peptide.
Fig. 1 Relative gene expression. a afr, b adhE, c nan_A3, d nanB, e yesO_2 and f ycjO expression was determined by real-time RT-PCR and is
displayed relative to the value of the lowest expression, after normalization using 16S RNA gene expression. The values are the means of four
(afr) or three (all other genes) separate experiments. Error bars indicate standard error., *p ≤ 0.05, **p≤ 0.01
Nasher et al. BMC Microbiology  (2018) 18:23 Page 6 of 11
No difference in inflammation or meningitis in response
to 110.58 or mutant ΔORF 2
Because ORF 2 peptide enhanced growth and AdhE has
been linked to inflammation, we tested whether the wild
type strain and mutants ΔORF 1 + 2 and ΔORF 2
differed in the inflammatory responses they induced in
vitro and in vivo. Figure 4 shows that Detroit epithelial
cells did not differ in their CXCL8 response to the
strains in the presence of 0.07 mg/ml ORF 2 ligand pep-
tide FPPQSV. For all strains the peptide increased
CXCL8 response to the bacteria but we interpret this as
being due to increased bacterial growth due to the
presence of the peptide. Peptide in the absence of bac-
teria had no effect on the release of CXCL8 from the
Detroit cells as shown in the negative control in Fig. 4.
We also tested whether 110.58 and ΔORF 1 + 2 dif-
fered in their ability to cause disease and inflammation
in an infant rat model of meningitis. 110.58 was not able
to establish a detectable infection in the CSF at 21 h post
infection (hpi) in any rat. For the rats which received the
mutant ΔORF 1 + 2, four had no detectable infection in
the CSF at 21 hpi, while two had very low levels: 9.5 and
6 × 104 CFU/ml. No disease, cortical damage, apoptosis
in the hippocampus or detection of any of the cytokines
Table 2 Proteins upregulated in wildtype strain 110.58 by exposure to ORF 2 ligand peptide FPPQSV
Protein number Protein name Function Ratioa q
AJD72675 Afr 1,5-anhydro-D-fructose reductase infiniteb 0
AJD71621 DivlB Cell division protein DivIB 7.1 0.004
AJD71961 PyrP Uracil transporter 3.8 0.01
AJD71716 ASCH domain protein, Predicted RNA-binding protein YhfF, could regulate translation 3.8 0.01
AJD73085 Hypothetical protein, N-ethylammeline chlorohydrolase, hydrolase activity,
acting on carbon-nitrogen (but not peptide) bonds
3.8 0.01
AJD71419 CitS Sensor protein 2.6 0.01
AJD71122 RibE Riboflavin synthase 2.3 0.01
AJD71434 trmB tRNA (guanine-N(7)-)-methyltransferase 2.3 0.01
AJD71098 Hypothetical protein, transcriptional activator, Rgg/GadR/MutR family 1.7 0.02
AJD71572 Hypothetical protein 1.4 0.05
AJD71120 RibH 6,7-dimethyl-8-ribityllumazine synthase 1.4 0.04
For the complete dataset for the wild type and ΔORF 2 mutant see Additional file 6: Table S5, Additional file 7: Table S6, Additional file 8: Table S7,
Additional file 9: Table S8
aRatio represents the fold increase in the protein in the presence of peptide FPPQSV compared to in its absence
bThe value in the absence of peptide was 0 so fold increase in the presence of peptide could not be calculated
Fig. 2 Growth of wild type strain 110.58 and mutant ΔORF 2 in CDM with and without 0.062 mg/ml ORF2 ligand peptide FPPQSV. Curves show
the mean values for three independent experiments
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IL-6, IL-1β, TNFα, IL-10, IFN-γ in the CSF at 21 or 45
hpi was detected in any rat (data not shown).
Discussion
Nonencapsulated pneumococci of ST344 which have the
genes aliB-like ORF 1 and 2 in place of capsule genes,
such as Swiss strain 110.58, are highly successful
colonizers of the human nasopharynx, an environment
where the concentration of free sugar is considered to
be limited [3]. AliB-like ORF 2 appears to aid the early
stages of nasopharyngeal colonization, at least in a
mouse model [1]. AliB-like ORF 2 can bind peptide
FPPQSV, a sequence found in Prevotella species, likely
neighbours in the nasopharyngeal niche, indicating a
potential route of interspecies communication [1]. For E.
coli, secreted proteins include ribosomal associated
proteins [25] and we speculate that Prevotella too can
release proteins usually considered to be intracellular.
Here, we aimed to answer the question of how binding
of AliB-like ORF 2 to its ligand may lead to improved
colonization. We propose that peptide FPPQSV acts as a
specific signal and that following the specific binding,
pneumococci respond by upregulating sialidase to pro-
duce more free carbohydrate, increasing carbohydrate
uptake and increasing carbohydrate metabolism. A per-
mease for the update of AliB-like ORF 2 peptide has not
yet been identified but due to the sequence homology of
AliB-like ORF 2 to substrate binding protein AliB, after
which it is named, we speculate that the Ami-AliA/AliB
transporter may be responsible for uptake. This oligo-
peptide permease has also been proposed to be the route
of entry into pneumococcus for Phr peptide of the
TprA/PhrA quorum sensing system [26]. TprA/PhrA in
strain D39 has also been shown to be activated by PhrA2
which is found in the pneumococcal lineage PMEN1 but
not in D39 indicating interstrain gene regulation [27].
a
b
Fig. 3 Competition assay in the presence or absence of ORF 2 peptide. A mixture of wild type strain 110.58 and its mutant ΔORF2 was incubated
in (a) the presence of 0.07 mg/ml of ORF2 ligand peptide FPPQSV or (b) the absence of peptide. At the start and at OD600nm = 0.2 and 0.3
CFU/ml were determined to show that the wild type has a competitive advantage and that this is greater in the presence of the peptide.
****p < 0.0001, *p = 0.015. Results are the mean of three independent experiments, error bars show the standard error
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Other peptides involved in quorum sensing in pneumo-
coccus include virulence peptide 1 (VP1) which
promotes biofilm development on chinchilla middle ear
epithelial cells [28] and a small hydrophobic peptide
(SHP) which induces capsule expression [29]. However,
the crucial difference between these quorum-sensing
studies and the work we present here is that we describe
the effect of non-streptococcal peptides on pneumococ-
cus i.e. interspecies communication.
In both the transcriptome and proteome data, multiple
genes related to carbohydrate metabolism were upregu-
lated by the presence of the ORF 2 peptide ligand. There
was a good correlation between these two datasets with
afr, encoding 1,5-anhydro-D-fructose reductase, increas-
ing in expression significantly in both when ORF 2
peptide was present. 1,5-anhydro-D-fructose reductase is
a metabolic enzyme which acts on 1,5-anhydro-D-fruc-
tose, the central intermediate of the anhydrofructose
pathway, an alternative starch- and glycogen degrading
pathway in bacteria, fungi, plants and mammals [30]. In
E. coli the anhydrofructose pathway is proposed to be in-
volved in the stress response related to carbon starvation
or reactive oxygen species [31]. Trappetti et al. have also
described a link between an interspecies signaling
molecule and carbohydrate metabolism in pneumococ-
cus: They found that autoinducer 2 (AI-2), is recognized
by FruA (a fructose-specific phosphoenolpyruvate-
phosphotransferase system) to enable pneumococcus to
use galactose, the predominant sugar source in the naso-
pharynx, as a carbon source [32].
Neuraminidase-encoding genes nanA and nanB both
had increased expression in response to ORF 2 peptide.
Neuraminidases are thought to cleave sialic acid from
cell surface glycans and mucin and both NanA and
NanB have been shown to be essential for successful
colonization in a mouse model [33]. Exposure of galactose
on epithelial cells by NanA promotes biofilm formation
during colonization [34]. In addition, deglycosylation of
host glycoconjugates by neuraminidases releasing mono-
saccharides provides S. pneumoniae with a source of
carbohydrate which can be used to sustain growth [35].
Upregulation of yesO and ycj genes was also noted in
the presence of ORF 2 peptide. These are thought to
encode components of an ABC transporter for carbohy-
drate uptake and are found immediately downstream of
nanB. Other genes upregulated by ORF 2 peptide
believed to be involved in carbohydrate transport and
metabolism were sorB_1, manX_1, agaS, agaC_1 and
adhE. tabA, proposed to encode a component of a
toxin-antitoxin involved in biofilm formation, was also
upregulated which is compatible with stepping up
colonization. The uracil transporter encoded by pyrP
was also of note as this was upregulated in both the
RNA and protein data. Cell division protein DivIB was
upregulated at the protein level as were RibE and RibH,
involved in riboflavin synthesis. Other genes were differ-
entially regulated as well and the strength of gene
expression is not necessary related to functional import-
ance. Therefore, it is possible that other pathways that
are not discussed here are also involved. In particular,
genes belonging to amino acid metabolism and transport
were upregulated.
These findings prompted us to look at the effect of
ORF 2 peptide on growth. Previously, we had failed to
detect a direct effect of the peptide on growth [1] but
here we analyzed growth over time in a defined medium
devoid of peptides until we added our ORF 2 peptide.
This confirmed that the ORF 2 peptide promotes
growth. This effect was also seen in the mutant lacking
the ORF 2 peptide receptor, although to a lesser extent.
This suggests that AliB-like ORF 2 is not the only recep-
tor for the peptide. However, in a competition assay in
the presence of the peptide, the wild type strain signifi-
cantly outcompeted the mutant lacking aliB-like ORF 2
indicating that in nature with multiple strains present,
having AliB-like ORF 2 would give an advantage in
growth and therefore colonization.
Nonencapsulated strains with aliB-like ORF 1 and 2
are associated with nasopharyngeal colonization [3] and
conjunctivitis [36] but not virulent disease. Our results
using an in vivo model of meningitis supported this as
neither the wild type nor mutant strain caused disease
Fig. 4 Effect of wild type pneumococcal strain 110.58 and its
mutants ΔORF 1 + 2 and ΔORF 2 on CXCL8 induction in human
nasopharyngeal Detroit 562 epithelial cells. ORF2 ligand peptide
FPPQSV was either not added (open bars) or added to give a final a
concentration of 0.07 mg/ml (shaded bars). No significant
differences were observed between the strains under the same
conditions. The bars indicate the mean of three independent
experiments and error bars indicate standard error. Negative control
refers to Detroit cells in the absence of bacteria
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when administered intracisternally. This may be due to
these nonencapsulated pneumococci being removed by
the immune system before any growth advantage of the
wild type strain becomes apparent. We also looked at
the effect of 110.58 and its mutants on human respira-
tory cells in vitro and found no difference in their ability
to stimulate the epithelial cells to release CXCL8, a
marker of an inflammatory response.
Conclusion
A peptide which matches proteins found in Prevotella
species acts on nonencapsulated pneumococci, which
have a specific receptor for it, to trigger a boost in
carbohydrate metabolism and thus growth. This would
seem to be the mechanism by which possession of AliB-
like ORF 2 aids colonization. Pneumococci, including
virulent encapsulated strains, possess other ABC trans-
porters of oligopeptides which warrant investigation as
potential sensors of signals from members of the
microbiota which could trigger responses in pneumo-
cocci during colonization and disease.
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